| Ident. | Authors (with country if any) | Title |
|---|
| 000081 (2020) |
Shuichiro Nakabo [Japon] ; Yuko Tsuji [Japon] ; Maiko Inagaki [Japon] ; Hideaki Tsuji [Japon] ; Toshiki Nakajima [Japon] ; Kosaku Murakami [Japon] ; Chikashi Terao [Japon] ; Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] ; Yasutomo Fujii [Japon] | Severe joint deformity and Patient Global Assessment of Disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients. |
| 000093 (2020) |
Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon] | Response to: 'Some concerns from Turkey' by Bilgin et al. |
| 000182 (2020) |
Kosuke Ebina [Japon] ; Toru Hirano [Japon] ; Yuichi Maeda [Japon] ; Wataru Yamamoto [Japon] ; Motomu Hashimoto [Japon] ; Koichi Murata [Japon] ; Tohru Takeuchi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Akira Onishi [Japon] ; Sadao Jinno [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Keiichi Yamamoto [Japon] ; Atsushi Kumanogoh [Japon] ; Makoto Hirao [Japon] | Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study. |
| 000362 (2019) |
Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon] | Response to: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee. |
| 000412 (2019) |
Noriko Iwamoto [Japon] ; Megumi Takanashi [Japon] ; Kotoko Yokoyama [Japon] ; Atsushi Yonezawa [Japon] ; Masaya Denda [Japon] ; Motomu Hashimoto [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Minoru Matsuura [Japon] ; Shuji Yamamoto [Japon] ; Yusuke Honzawa [Japon] ; Kazuo Matsubara [Japon] ; Takashi Shimada [Japon] | Multiplexed monitoring of therapeutic antibodies for inflammatory diseases using Fab-selective proteolysis nSMOL coupled with LC-MS. |
| 000502 (2019) |
Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon] | Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study. |
| 000503 (2019) |
Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon] | Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study. |
| 000581 (2019) |
Noriko Iwamoto [États-Unis] ; Atsushi Yonezawa [Japon] ; Kazuo Matsubara [Japon] ; Takashi Shimada [États-Unis] | Acceleration of nano-surface and molecular-orientation limited (nSMOL) proteolysis with acidified reduction pretreatment for quantification of Tocilizumab. |
| 000640 (2018) |
Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonoti Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon] | Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial. |
| 000818 (2018) |
Tatiana A. Karakasheva [États-Unis] ; Eric W. Lin [États-Unis] ; Qiaosi Tang [États-Unis] ; Edmund Qiao [États-Unis] ; Todd J. Waldron [États-Unis] ; Monica Soni [États-Unis] ; Andres J. Klein-Szanto [États-Unis] ; Varun Sahu [États-Unis] ; Devraj Basu [États-Unis] ; Shinya Ohashi [Japon] ; Kiichiro Baba [Japon] ; Zachary T. Giaccone [États-Unis] ; Sarah R. Walker [États-Unis] ; David A. Frank [États-Unis] ; E Paul Wileyto [États-Unis] ; Qi Long [États-Unis] ; Margaret C. Dunagin [États-Unis] ; Arjun Raj [États-Unis] ; J Alan Diehl [États-Unis] ; K K Wong [États-Unis] ; Adam J. Bass [États-Unis] ; Anil K. Rustgi [États-Unis] | IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. |
| 000830 (2018) |
Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Wararu Yamamoto [Japon] ; Takanori Fujimura [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Ohnishi [Japon] ; Kengo Akashi [Japon] ; Shuzo Yoshida [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Toru Hirano [Japon] ; Kosuke Ebina [Japon] ; Ryuji Uozumi [Japon] ; Hiromu Ito [Japon] ; Masao Tanaka [Japon] ; Koichiro Ohmura [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] | Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study. |
| 000861 (2018) |
Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Akira Ohnishi [Japon] ; Daijiro Kabata [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Shuzo Yoshida [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Kengo Akashi [Japon] ; Takanori Fujimura [Japon] ; Makoto Hirao [Japon] ; Keiichi Yamamoto [Japon] ; Ayumi Shintani [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon] | Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study. |
| 000C85 (2016) |
Naonobu Sugiyama [Japon] ; Yutaka Kawahito [Japon] ; Takao Fujii [Japon] ; Tatsuya Atsumi [Japon] ; Tatsunori Murata [Japon] ; Yosuke Morishima [Japon] ; Yuri Fukuma [Japon] | Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data. |
| 000D76 (2016) |
Yasufumi Masaki [Japon] ; Hiroshi Kawabata [Japon] ; Kazue Takai [Japon] ; Masaru Kojima [Japon] ; Norifumi Tsukamoto [Japon] ; Yasuhito Ishigaki [Japon] ; Nozomu Kurose [Japon] ; Makoto Ide [Japon] ; Jun Murakami [Japon] ; Kenji Nara [Japon] ; Hiroshi Yamamoto [Japon] ; Yoko Ozawa [Japon] ; Hidekazu Takahashi [Japon] ; Katsuhiro Miura [Japon] ; Tsutomu Miyauchi [Japon] ; Shinichirou Yoshida [Japon] ; Akihito Momoi [Japon] ; Nobuyasu Awano [Japon] ; Soichiro Ikushima [Japon] ; Yasunori Ohta [Japon] ; Natsue Furuta [Japon] ; Shino Fujimoto [Japon] ; Haruka Kawanami [Japon] ; Tomoyuki Sakai [Japon] ; Takafumi Kawanami [Japon] ; Yoshimasa Fujita [Japon] ; Toshihiro Fukushima [Japon] ; Shigeo Nakamura [Japon] ; Tomohiro Kinoshita [Japon] ; Sadao Aoki [Japon] | Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. |
| 001013 (2015) |
Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon] | Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. |
| 001111 (2015) |
Ryoko Sakai [Japon] ; Soo-Kyung Cho [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Michi Tanaka [Japon] ; Ryuji Koike [Japon] ; Yoshiya Tanaka [Japon] ; Kazuyoshi Saito [Japon] ; Shintaro Hirata [Japon] ; Koichi Amano [Japon] ; Hayato Nagasawa [Japon] ; Takayuki Sumida [Japon] ; Taichi Hayashi [Japon] ; Takahiko Sugihara [Japon] ; Hiroaki Dobashi [Japon] ; Shinsuke Yasuda [Japon] ; Tetsuji Sawada [Japon] ; Kazuhiko Ezawa [Japon] ; Atsuhisa Ueda [Japon] ; Takao Fujii [Japon] ; Kiyoshi Migita [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon] | Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry. |
| 001345 (2014) |
Motomu Hashimoto [Japon] ; Takao Fujii [Japon] ; Masahide Hamaguchi [Japon] ; Moritoshi Furu [Japon] ; Hiromu Ito [Japon] ; Chikashi Terao [Japon] ; Keiichi Yamamoto [Japon] ; Wataru Yamamoto [Japon] ; Takashi Matsuo [Japon] ; Masato Mori [Japon] ; Koichiro Ohmura [Japon] ; Hiroshi Kawabata [Japon] ; Tsuneyo Mimori [Japon] | Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis. |
| 001425 (2014) |
Hisashi Urushihara [Japon] ; Koji Kawakami [Japon] | Academic Clinical Trials and Drug Regulations in Japan: Impacts of Introducing the Investigational New Drug System. |
| 001507 (2013) |
Hiroshi Kawabata [Japon] ; Shin-Ichi Kotani ; Yumi Matsumura ; Tadakazu Kondo ; Tatsuya Katsurada ; Hironori Haga ; Norimitsu Kadowaki ; Akifumi Takaori-Kondo | Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody. |
| 001611 (2013) |
Hiroshi Kawabata [Japon] ; Norimitsu Kadowaki ; Momoko Nishikori ; Toshio Kitawaki ; Tadakazu Kondo ; Takayuki Ishikawa ; Hajime Yoshifuji ; Noriyuki Yamakawa ; Yoshitaka Imura ; Tsuneyo Mimori ; Yumi Matsumura ; Yoshiki Miyachi ; Takeshi Matsubara ; Motoko Yanagita ; Hironori Haga ; Akifumi Takaori-Kondo | Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. |
| 001615 (2013) |
Hiroshi Kawabata [Japon] ; Kazue Takai ; Masaru Kojima ; Naoya Nakamura ; Sadao Aoki ; Shigeo Nakamura ; Tomohiro Kinoshita ; Yasufumi Masaki | Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). |
